Health
Stiff person syndrome patients share what it’s like to live with the rare disease
This story discusses suicide. If you or someone you know is having thoughts of suicide, please contact the Suicide & Crisis Lifeline at 988 or 1-800-273-TALK (8255).
A little-known neurological disorder has been thrust into the spotlight after a documentary revealed singer Celine Dion’s struggle with stiff person syndrome (SPS).
The disease is rare, affecting only one or two people for every million. Yet for those who are diagnosed, it can have a devastating impact, causing muscle rigidity, pain and spasms.
LIKE CELINE DION, PENNSYLVANIA MAN IS FIGHTING STIFF PERSON SYNDROM WITH ‘EVERYTHING I HAVE’
Two people who are living with stiff person syndrome — Carrie Robinette, 45, from San Diego, California, and Corwyn Wilkey, 44, who lives in Anchorage, Alaska — shared with Fox News Digital the details of their experience.
Path to diagnosis
Robinette, a Navy wife and mother who was working as a full-time defense consultant, had been dealing with multiple health issues — pain, neuropathy, fatigue, migraines, asthma, allergies, thyroid and endocrine issues, kidney issues, even cancer — for more than 15 years.
“I was honestly ‘always sick’ from the time I was born,” she said in a phone interview with Fox News Digital.
Two people who are living with stiff person syndrome — Carrie Robinette, 45, from San Diego, California, at left, and Corwyn Wilkey, 44, who lives in Anchorage, Alaska, right — shared with Fox News Digital what their experiences have been. (Carrie Robinette/Corwyn Wilkey)
“Also, even as far back as high school, I had incredibly tight muscles in my legs, and there were countless times that I woke up crying with charley horse cramps in my calves.”
Then, in May 2023, Robinette began experiencing painful, full-body spasms.
LUPUS EXPERT DEBUNKS 7 COMMON MYTHS ABOUT THE AUTOIMMUNE DISEASE: ‘NOT A DEATH SENTENCE’
That kicked off a year of testing and visits to specialists in rheumatology, nephrology, endocrinology and neurology.
“After learning more and going back through my medical history, we realized that symptoms we previously blamed on other causes were likely early signs of stiff person syndrome.”
Over the last year, as Robinette’s “constellation of symptoms” intensified, the doctors finally narrowed it down.
“It is beyond frustrating to literally not know at the start of each day if it will be a good day or a bad day.”
“There is not a consensus within the SPS community on exact diagnostic criteria, and some doctors seem hesitant to diagnose rare diseases, so the journey to diagnosis is complicated by how rare the illness is,” Robinette said.
“Definitive testing is not readily available.”
Robinette, at left, receives treatment for her stiff person syndrome at a San Diego hospital. (Carrie Robinette)
These days, Robinette’s biggest challenge is frequent pain.
“Even if my body is not actively spasming, it feels like my muscles are sore, even bruised — all day, every day,” she said. “I think eventually, we grow accustomed to our pain, so it just becomes the new normal.”
Some days, Robinette can walk and move “almost like normal,” while other days she can’t walk without a cane or walker.
THE GIRL WHO CAN’T SMILE: HOW A RARE DISORDER BECAME A YOUNG WOMAN’S ‘GREATEST GIFT’
She regularly uses a mobility chair when traveling any distance beyond 50 feet.
“It is beyond frustrating to literally not know at the start of each day if it will be a good day or a bad day.”
‘Initial symptoms’
Wilkey, a father of young children who works as an interpretive media publications specialist for Alaska State Park and is also a singer, first noticed muscle spasms in his larynx while performing with his band.
As a musician, Corwyn Wilkey said his symptoms share some similarities to Celine Dion’s. “My initial symptoms were throat and facial spasms that have progressed into full-body seizures,” he told Fox News Digital. (Corwyn Wilkey)
“Like Celine Dion, my initial symptoms were throat and facial spasms that have progressed into full-body seizures,” he told Fox News Digital via email.
Wilkey was officially diagnosed with stiff person syndrome in 2021 at the Mayo Clinic in Rochester, Minnesota.
PENNSYLVANIA MOM SEEKS ‘PERFECT MATCH’ BONE MARROW DONOR TO CURE DAUGHTER’S RARE DISORDER: ‘CRUCIAL NEED’
“The most prominent physical challenges are muscle stiffness and rigidity, seizure-like muscle spasms, cognitive distortion and decline, chronic pain and fatigue, PTSD, loss of coordination and fine motor control, headaches, joint pain, back pain, and inability to coordinate my body the way I want to,” he said.
Wilkey’s full-body spasms are sometimes strong enough to dislocate and even fracture bones, he said.
James Chung, M.D., PhD, chief medical officer at Kyverna Therapeutics in Emeryville, California, noted that diagnosis of stiff person syndrome is a complex process. (He has not treated either of the patients mentioned in this article.)
James Chung, M.D., PhD, chief medical officer at Kyverna Therapeutics in Emeryville, California, said a diagnosis of stiff person syndrome is a complex process. (Dr. James Chung)
“We start with a detailed clinical evaluation, looking for characteristic muscle rigidity and spasms,” Chung, who focuses on drug development for autoimmune diseases, told Fox News Digital via email.
FDA APPROVES NEW DRUG TO TREAT AUTOIMMUNE LIVER DISEASE: ‘GIANT STEP FORWARD’
Blood tests are also needed to detect the antibodies that are found in a majority of cases, he said.
“Given the rarity of SPS, patients often feel misunderstood, even by health care professionals.”
“Electromyography (EMG) is essential, showing continuous motor unit activity in affected muscles,” he said.
In many cases, doctors will perform a lumbar puncture (spinal tap) to analyze cerebrospinal fluid for elevated antibodies and to rule out other conditions, along with imaging scans.
“SPS is often a diagnosis of exclusion due to its rarity,” Chung said.
Limited treatments
While there is currently no cure for stiff person syndrome, therapies can help manage symptoms and improve patients’ quality of life.
Treatments are highly personalized for each patient, according to Chung.
Robinette shows what her life looks like with SPS. “For now, unfortunately, I am currently battling my condition without any helpful medications.” (Carrie Robinette)
In most cases, patients take medications like diazepam and baclofen to reduce muscle stiffness and spasms, and may take intravenous immunotherapies to help reduce autoantibodies.
“Pain management often involves a combination of medications,” Chung said. “Physical and occupational therapy are vital.”
Some current medications can have intense side effects, however.
RARE CONDITION CAUSED PATIENT TO SEE ‘DEMONIC’ FACES, SAYS STUDY ON ‘VISUAL DISORDER’
Robinette has experienced hallucinations, loss of muscle control, nausea, vomiting and brain fog.
“For now, unfortunately, I am currently battling my condition without any helpful medications, and it is nearly unbearable,” she said.
Kyverna Therapeutics is currently developing a new CAR-T cell therapy, KYV-101, that aims to “reset” the immune systems of patients with autoimmune diseases, according to Chung.
Wilkey, pictured with his children, endured a dark time after his diagnosis. “I lost everything — my marriage, all my money, my home and even my children for a time,” he said. (Corwyn Wilkey)
“This approach could potentially offer a more targeted treatment that addresses the root cause of SPS rather than just managing symptoms,” he said.
The drug has recently gotten FDA approval to enter phase 2 clinical trials.
“I can really see it being the life-changing treatment that so many people with SPS and other autoimmune conditions need,” said Robinette. “I just wish science moved faster!”
Mental and emotional effects
Many patients with stiff person syndrome struggle with anxiety about experiencing spasms in public, which often leads to social isolation, according to Chung.
“Depression is common, stemming from chronic pain, loss of independence and the disease’s unpredictable nature,” he told Fox News Digital.
NEW JERSEY TWINS RECEIVE MATCHING HEART SURGERIES AFTER MARFAN SYNDROME DIAGNOSIS: ‘A BETTER LIFE’
“Patients also frequently experience frustration with the medical system due to misdiagnosis or dismissal of symptoms,” he added.
“Given the rarity of SPS, patients often feel misunderstood, even by health care professionals.”
When Wilkey received his diagnosis, he struggled with treatment-resistant depression, PTSD and complex regional pain syndrome, he told Fox News Digital.
“This past year, on my journey with SPS, my family and I have really been put through the wringer,” Robinette told Fox News Digital. (Carrie Robinette)
“The difficulties associated with the disease destroyed my marriage and, for a time, turned me into a rage monster,” he said.
“It has felt very much like receiving a death sentence.”
To treat his “incredible” pain, Wilkey was prescribed oxycodone and morphine, which ultimately led to addiction.
OHIO BOY, 8, PREPARES FOR BLINDNESS: ‘IT’S HEARTBREAKING,’ HIS MOM SAYS
“I became unable to function and felt like a burden on my family, which led me to attempt suicide,” he said.
Wilkey underwent a period of hospitalization, intensive therapy and pain rehabilitation programs.
“I lost everything — my marriage, all my money, my home and even my children for a time,” he said.
Today, Wilkey continues to participate in palliative care therapy, as well as psychedelic-assisted therapy for PTSD and depression. (Corwyn Wilkey)
Today, Wilkey continues to participate in palliative care therapy — as SPS is considered a progressive and terminal disease — as well as psychedelic-assisted therapy for PTSD and depression.
Robinette has also experienced mental and emotional challenges stemming from her disease.
“This past year, on my journey with SPS, my family and I have really been put through the wringer,” she told Fox News Digital.
“It takes a toll to feel like you are in a medical crisis and yet know that even if you go to the hospital, no one will help you.”
“Seizing, in 10 out of 10 pain, losing control of muscles, and having the body twist and contort into a terrifying, seemingly endless episode — some of these events last 10 to 60 minutes, which feels like an eternity.”
The hardest part, she said, is that some doctors have told her, “It could be in your head,” or “We can’t help you because we aren’t sure what it is.”
“It takes a toll to feel like you are in a medical crisis and yet know that even if you go to the hospital, no one will help you,” Robinette said.
Celine Dion was diagnosed with stiff person syndrome in 2022. (Neilson Barnard/Getty Images for The Recording Academy)
“I think it would make a world of difference to SPS patients to not have the added stress of having to constantly have to advocate for care.”
Stress management is crucial for SPS patients, Chung said, as emotional stress can trigger or worsen spasms.
“Supporting mental health is a key component of comprehensive SPS care.”
Who is most at risk?
Stiff person syndrome is a progressive and ultimately terminal neuromuscular autoimmune disease.
SPS shows certain demographic patterns, Chung said.
“It is incredibly empowering to know that you are not alone.”
“Women are more commonly affected, with a 2:1 ratio compared to men,” he said.
The typical age of diagnosis is between 30 and 60 years of age.
“There’s a strong association with other autoimmune disorders,” Chung said, which can complicate the diagnosis process.
“About 30% to 40% of SPS patients have type 1 diabetes, and we see higher rates of thyroiditis, vitiligo and pernicious anemia,” the doctor went on.
“This clustering suggests a genetic predisposition to autoimmunity, although we haven’t identified specific genes for SPS.”
Advice for handling a diagnosis
For those who are living with stiff person syndrome, Chung said the best course of action is to get education from reliable sources and to build a strong support network.
“Work closely with a multidisciplinary medical team, be proactive in your treatment and communicate openly with your health care providers,” he advised.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The doctor also recommended practicing stress-reduction techniques and staying as physically active as safely possible under professional guidance.
Robinette is pictured with her husband, Jared Robinette, who she said has given her “incredible support” throughout her struggle with stiff person syndrome. “He has been at my side through every terrifying episode,” she said. “He has gone above and beyond caring for me. I am truly lucky to have such a kind and thoughtful partner.” (Carrie Robinette)
Wilkey’s best advice: “Don’t try and go it alone.”
He said, “You will drive yourself insane and beat your head against the wall, trying to cope on your own. Connecting with other survivors and developing a solid support system of crucial allies is essential.”
For Robinette, sharing her story has been a helpful coping mechanism.
“It is incredibly empowering to know that you are not alone,” she said.
For more Health articles, visit www.foxnews/health
“I believe that the more our voices rise, the more chance we all have of being heard.”
Those seeking more information and resources for stiff person syndrome can visit The Stiff Person Syndrome Research Foundation at www.stiffperson.org.
Health
Aging process could accelerate due to ‘forever chemicals’ exposure, study finds
NEWYou can now listen to Fox News articles!
A new study suggests that middle-aged men may be more vulnerable to faster biological aging, potentially linked to exposure to “forever chemicals.”
The research, published in the journal Frontiers in Aging, examined how perfluoroalkyl and polyfluoroalkyl substances, more commonly known as PFAS, could impact aging at the cellular level.
PFAS are synthetic chemicals commonly used in nonstick cookware, food packaging, water-resistant fabrics and other consumer products, the study noted.
Their chemical structure makes them highly resistant to breaking down, allowing them to accumulate in water, soil and the human body.
Chinese researchers analyzed blood samples from 326 adults enrolled in the U.S. National Health and Nutrition Examination Survey between 1999 and 2000.
A new study suggests that middle-aged men could face accelerated biological aging at the cellular level due to exposure to PFAS. (iStock)
The researchers measured levels of 11 PFAS compounds in participants’ blood and used DNA-based “epigenetic clocks” — tools that analyze chemical changes to DNA to estimate biological age — to determine how quickly their bodies were aging at the cellular level, the study stated.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Two compounds, perfluorononanoic acid (PFNA) and perfluorooctanesulfonamide (PFOSA), were detected in 95% of participants.
Higher concentrations of those chemicals were associated with faster biological aging in men of certain age groups, but not in women.
“People should not panic.”
The compounds most strongly linked to accelerated aging were not the PFAS chemicals that typically receive the most public attention, the researchers noted.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“The associations were strongest in adults aged 50 to 64, particularly in men,” Dr. Xiangwei Li, professor at Shanghai Jiao Tong University School of Medicine and the study’s corresponding author, told Fox News Digital.
“While this does not establish that PFAS cause aging, it suggests that these widely present ‘forever chemicals’ may be linked to molecular changes related to long-term health and aging.”
The study found that two of the compounds were detected in 95% of participants, and higher levels were linked to faster biological aging in men ages 50–64. (iStock)
Midlife may represent a more sensitive biological period, when the body becomes more vulnerable to age-related stressors, according to the researchers.
Lifestyle factors, such as smoking, may influence biological aging markers, potentially increasing vulnerability to environmental pollutants.
While Li said “people should not panic,” she does recommend looking for reasonable ways to reduce exposure.
That might mean checking local drinking water reports, using certified water filters designed to reduce PFAS, and limiting the use of stain- or grease-resistant products when alternatives are available.
CLICK HERE FOR MORE LIFESTYLE STORIES
Meaningful reductions in PFAS exposure will likely depend on broader regulatory action and environmental cleanup efforts, Li added.
The researchers noted that midlife could be a particularly sensitive stage, when the body is more susceptible to stressors associated with aging. (iStock)
Study limitations
The researchers outlined several important limitations of the research, including that the findings show an association, but do not prove that PFAS directly causes accelerated aging.
“The study is cross-sectional, meaning exposure and aging markers were measured at the same time, so we cannot determine causality,” Li told Fox News Digital.
The study was also relatively small, limited to 326 adults age 50 or older, which means the findings may not apply to younger people or broader populations.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Researchers measured PFAS levels using data collected between 1999 and 2000, and today’s exposure patterns may differ.
Li added that while PFAS is known to persist in the environment and the body, these results should be validated through larger, more recent studies that follow participants over time.
Health
Melissa Joan Hart, 49, Opens up About Weight Loss in Perimenopause
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Health
Alzheimer’s prevention breakthrough found in decades-old seizure drug
NEWYou can now listen to Fox News articles!
A drug that has long been used to treat seizures has shown promise as a potential means of Alzheimer’s prevention, a new study suggests.
The anti-seizure medication, levetiracetam, was first approved by the FDA in November 1999 under the brand name Keppra as a therapy for partial-onset seizures in adults. The approval has since expanded to include children and other types of seizures.
Northwestern University researchers recently found that levetiracetam prevented the formation of toxic amyloid beta peptides, which are small protein fragments in the brain that are commonly seen in Alzheimer’s patients.
The medication was found to prevent the formation of amyloid-beta 42 in both animal models and cultured human neurons, according to the study findings, which were published in Science Translational Medicine.
The effect was also seen in post-mortem human brain tissue obtained from individuals with Down syndrome, who are at high risk for Alzheimer’s disease.
The medication was found to prevent the formation of amyloid-beta 42 in both animal models and cultured human neurons. (iStock)
“While many of the Alzheimer’s drugs currently on the market, such as lecanemab and donanemab, are approved to clear existing amyloid plaques, we’ve identified this mechanism that prevents the production of the amyloid‑beta 42 peptides and amyloid plaques,” said corresponding author Jeffrey Savas, associate professor of behavioral neurology at Northwestern University Feinberg School of Medicine, in a press release.
“Our new results uncovered new biology while also opening doors for new drug targets.”
HIDDEN BRAIN CONDITION MAY QUADRUPLE DEMENTIA RISK IN OLDER ADULTS, STUDY SUGGESTS
The brain is better able to avoid the pathway that produces toxic amyloid‑beta 42 proteins in younger years, but the aging process gradually weakens that ability, Savas noted.
“This is not a statement of disease; this is just a part of aging. But in brains developing Alzheimer’s, too many neurons go astray, and that’s when you get amyloid-beta 42 production,” he said.
The effect was also seen in post-mortem human brain tissue obtained from individuals with Down syndrome, who are at high risk for Alzheimer’s disease. (iStock)
That then leads to tau (“tangles”) — abnormal clumps of protein inside brain neurons — which can kill brain cells, trigger neuroinflammation and lead to dementia.
In order for levetiracetam to function as an Alzheimer’s blocker, high-risk patients would have to start taking it “very, very early,” Savas said — up to 20 years before elevated amyloid-beta 42 levels would be detected.
CLICK HERE FOR MORE HEALTH STORIES
“You couldn’t take this when you already have dementia, because the brain has already undergone a number of irreversible changes and a lot of cell death,” the researcher noted.
The researchers also did a deep dive into previous human clinical data to determine whether Alzheimer’s patients who were taking the anti-seizure drug had slower cognitive decline. They reported that the patients in that category had a “significant delay” in the span from cognitive decline to death compared to those not taking the drug.
“This analysis supports the positive effect of levetiracetam to slow the progression of Alzheimer’s pathology,” the researcher said. (iStock)
“Although the magnitude of change was small (on the scale of a few years), this analysis supports the positive effect of levetiracetam to slow the progression of Alzheimer’s pathology,” Savas said.
Looking ahead, the research team aims to find people who have genetic forms of Alzheimer’s to participate in testing, Savas said.
Limitations and caveats
The study had several limitations, including that it relied on animal models and cultured cells, with no human trials conducted.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Because the study was observational in nature, it can’t prove that the medication caused the prevention of the toxic brain proteins, the researchers acknowledged.
Savas noted that levetiracetam “is not perfect,” cautioning that it breaks down in the body very quickly.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The team is currently working to create a “better version” that would last longer in the body and “better target the mechanism that prevents the production of the plaques.”
“You couldn’t take this when you already have dementia, because the brain has already undergone a number of irreversible changes and a lot of cell death.”
The medication’s common documented side effects include drowsiness, weakness, dizziness, irritability, headache, loss of appetite and nasal congestion.
It has also been linked to potential mood and behavior changes, including anxiety, depression, agitation and aggression, according to the prescribing information. In rare cases, it could lead to severe allergic reactions, skin reactions, blood disorders and suicidal ideation.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Funding for the study was provided by the National Institutes of Health and the Cure Alzheimer’s Fund.
Fox News Digital reached out to the drug manufacturer and the researchers for comment.
-
World7 days agoExclusive: DeepSeek withholds latest AI model from US chipmakers including Nvidia, sources say
-
Massachusetts7 days agoMother and daughter injured in Taunton house explosion
-
Denver, CO7 days ago10 acres charred, 5 injured in Thornton grass fire, evacuation orders lifted
-
Louisiana1 week agoWildfire near Gum Swamp Road in Livingston Parish now under control; more than 200 acres burned
-
Florida3 days agoFlorida man rescued after being stuck in shoulder-deep mud for days
-
Oregon5 days ago2026 OSAA Oregon Wrestling State Championship Results And Brackets – FloWrestling
-
Maryland3 days agoAM showers Sunday in Maryland
-
Wisconsin3 days agoSetting sail on iceboats across a frozen lake in Wisconsin